Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02026466 · ClinicalTrials.gov registry record
Outcomes, Patient Health Status, and Efficiency in Chronic Total Occlusion
A clinical trial, sponsored by Saint Luke's Health System.
- Completed
- Registry status
- 1,000
- Enrollment target
NCT02026466: Completed study, sponsored by Saint Luke's Health System.
NCT02026466 is a clinical trial that has completed, run by Saint Luke's Health System. The registered enrollment target is 1,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02026466 has completed, sponsored by Saint Luke's Health System.
- COMPLETED
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
This is an observational registry, sponsored by Saint Luke's Hospital. This study is to be conducted according to DHHS Guidelines, applicable state regulations, and local IRB policies and procedures. The overall objective is to address current gaps in knowledge regarding CTO-PCI, as a prospective, multi-center, single-arm study of 1,000 participants.
Primary Outcome
Quantify the baseline health status effects of CTO among patients selected for CTO-PCI and quantify the changes associated with CTO-PCI using the Hybrid Approach.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2013-12 |
| Est. Completion | 2017-12 |
What the finished NCT02026466 record still lists
NCT02026466 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02026466 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02026466 about?
NCT02026466 is a clinical study titled "Outcomes, Patient Health Status, and Efficiency in Chronic Total Occlusion". This is an observational registry, sponsored by Saint Luke's Hospital. This study is to be conducted according to DHHS Guidelines, applicable state regulations, and local IRB policies and procedures. The overall objective is to address current gaps in knowledge regarding CTO-PCI, as a prospective, m...
What is the current status of trial NCT02026466?
This trial is currently completed. The enrollment target is 1,000 participants. The study started on 2013-12. Estimated completion is 2017-12.
Who is sponsoring clinical trial NCT02026466?
This trial is sponsored by Saint Luke's Health System, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia